EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Exploring potential anti-inflammatory effects of medicinal cannabis

Taylan Gurgenci, Gregor Kijanka, Ristan Greer, Georgie Huggett, Phillip Good, Md Moniruzzaman, Janet Hardy iD

Supportive Care in Cancer · 2023-11 · 31 (11)

DOI: 10.1007/s00520-023-08069-8 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 14.10.2023. Verfasst von Taylan Gurgenci und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department Palliative and Supportive Care, 10th floor, Mater Health Services, Raymond Tce, South Brisbane, Queensland, 4101, Australia. Hauptthemen laut MEDLINE: Medical Marijuana, Cannabidiol, Cannabis, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Inflammation is thought to play a key role in malignant disease and may play a significant part in the expression of cancer-related symptoms. Cannabidiol (CBD) is a bioactive compound in cannabis and is reported to have significant anti-inflammatory properties.

Method

Serial C-reactive protein (CRP) levels were measured in all participants recruited to a randomised controlled trial of CBD versus placebo in patients with symptoms related to advanced cancer. A panel of inflammatory cytokines was measured over time in a subset of these patients.

Results

There was no difference between the two arms in the trajectory of CRP or cytokine levels from baseline to day 28.

Conclusion

We were unable to demonstrate an anti-inflammatory effect of CBD in cancer patients.

Trial registration

ANZCTR 26180001220257, registered 20/07/2018.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical MarijuanaCannabidiolCannabisNeoplasmsHumansAnti-Inflammatory Agents

Stichwörter der Autor:innen

Advanced cancerInflammationInflammatory cytokinesMedicinal cannabis

Substanzen

Medical MarijuanaCannabidiolAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department Palliative and Supportive Care, 10th floor, Mater Health Services, Raymond Tce, South Brisbane, Queensland, 4101, Australia.
  • Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia.
  • Queensland Micro- and Nanotechnology Centre, Griffith University, Nathan, Queensland, Australia.
  • Torus Research, Brisbane, Queensland, Australia.
  • Department of Palliative Care, St Vincent's Private Hospital Brisbane, Brisbane, Queensland, Australia.
  • School of Pharmacy, The University of Queensland, Brisbane, Australia.

ORCID-Profile: Janet Hardy

Förderung

  • The University of Queensland

Zitieren

APA

Gurgenci, T., Kijanka, G., Greer, R., Huggett, G., Good, P., Moniruzzaman, M., & Hardy, J. (2023). Exploring potential anti-inflammatory effects of medicinal cannabis. Supportive Care in Cancer, 31(11). https://doi.org/10.1007/s00520-023-08069-8

Vancouver

Gurgenci T, Kijanka G, Greer R, Huggett G, Good P, Moniruzzaman M, et al. Exploring potential anti-inflammatory effects of medicinal cannabis. Supportive Care in Cancer. 2023;31(11). doi:10.1007/s00520-023-08069-8

BibTeX
@article{Gurgenci2023,
  author = {Gurgenci, Taylan and Kijanka, Gregor and Greer, Ristan and Huggett, Georgie and Good, Phillip and Moniruzzaman, Md and Hardy, Janet},
  title = {Exploring potential anti-inflammatory effects of medicinal cannabis},
  journal = {Supportive Care in Cancer},
  year = {2023},
  volume = {31},
  number = {11},
  doi = {10.1007/s00520-023-08069-8}
}
Kostenlos starten →